HowShorted

How shorted is Aura Biosciences, Inc.?

More shorted than 80% of the 2,877 ranked US companies

9.91%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
+1.17
5 reports (~10 weeks)
+4.99
Aggregate net short position time series for Aura Biosciences, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 20269.91%+1.17
15 Jul 20268.74%−2.07
30 Jun 202610.81%+2.41
15 Jun 20268.40%+2.53
29 May 20265.87%+0.95
15 May 20264.92%+1.50
30 Apr 20263.42%+0.28
15 Apr 20263.14%−0.94
31 Mar 20264.08%+0.13
13 Mar 20263.95%+0.41
27 Feb 20263.54%−1.00
13 Feb 20264.54%−0.44
30 Jan 20264.98%−0.05
15 Jan 20265.03%+0.03
31 Dec 20255.00%+0.18
15 Dec 20254.82%−0.27
28 Nov 20255.09%+0.49
14 Nov 20254.60%−0.11
31 Oct 20254.71%−0.35
15 Oct 20255.06%+0.01
30 Sep 20255.05%+0.35
15 Sep 20254.70%+0.20
29 Aug 20254.50%+0.09
15 Aug 20254.41%−1.09
31 Jul 20255.50%–

Frequently asked questions

How shorted is Aura Biosciences, Inc. right now?
9.91% of Aura Biosciences, Inc.'s (AURA) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.